Physician profile
Yuna Lee
NPI 1326680281
$2,799.16
in general payments reported to CMS, 2019-2025
16 companies · $785 in 2025
The $785 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $176 · 2022: $135 · 2023: $1,219 · 2024: $484 · 2025: $785.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,487.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $501.28 | 2023-2025 | Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $371.17 | 2023-2024 | Arexvy |
| Gilead Sciences, INC. | $349.75 | 2023 | Vemlidy |
| Madrigal Pharmaceuticals | $260.03 | 2024-2025 | Rezdiffra |
| Lilly USA, LLC | $249.83 | 2023-2024 | Jardiance, Mounjaro |
| Ipsen Biopharmaceuticals, INC | $243.46 | 2024-2025 | Iqirvo |
| Exact Sciences Corporation | $125.00 | 2025 | The Cologuard Plus Collection Kit |
| Oyster Point Pharma, INC. | $120.16 | 2023 | Tyrvaya |
| Astrazeneca Pharmaceuticals LP | $119.30 | 2023 | Farxiga |
| Dynavax Technologies Corporation | $115.84 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $102.34 | 2023 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $100.54 | 2021 | |
| Abbvie INC. | $72.57 | 2021-2024 | |
| Amgen INC. | $31.52 | 2023 | Evenity, Prolia |
| Siemens Medical Solutions USA, INC. | $19.48 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $16.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yuna Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.